Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

BGI Rumored to Stage $400 Million IPO in Late 2014

publication date: Feb 24, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
BGI Tech is planning a $400 million IPO in Hong Kong late in 2014. BGI Tech is a division of Shenzhen’s huge genomic sequencing company BGI. The Tech division, which is reponsible for a majority of the parent company's income, provides contract sequencing and bioinformatics services to pharmas, agricultural and environmental companies. The IPO has been rumored since last September. Even though the offering has not yet been officially confirmed, details are starting to emerge. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...